685
Views
90
CrossRef citations to date
0
Altmetric
Research Article

Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium

, , , , , & show all
Pages 543-552 | Received 22 Mar 2009, Accepted 20 May 2009, Published online: 16 Jun 2009

References

  • Brooking J, Davis SS, Illum L. (2001). Transport of nanoparticles across the rat nasal mucosa. J Drug Target, 9, 267–279.
  • Burd GD. (1991). Development of the olfactory nerve in the African clawed frog, Xenopus laevis: 1. Normal development. J Comp Neurol, 304, 123–134.
  • Dahlin M, Jansson B, Bjork E. (2001). Levels of dopamine in blood and brain following nasal administration to rats. Eur J Pharm Sci, 14, 75–80.
  • De Campos AM, Sanchez A, Gref R, Calvo P, Alonso MJ. (2003). The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. Eur J Pharm Sci, 20, 73–81.
  • De Lorenzo. 1970. Taste and Smell in vertebrates. J & A Churchill, London.
  • De Lorenzo A. (1960). Electron microscopy of the olfactory and gustatory pathways. Ann Otol Rhinol Laryngol, 68, 410–420.
  • Gao X, Chen J, Tao W, Zhu J, Zhang Q, Chen H, Jiang X. (2007a). UEA I-bearing nanoparticles for brain delivery following intranasal administration. Int J Pharm, 340, 207–215.
  • Gao X, Wu B, Zhang Q, Chen J, Zhu J, Zhang W, Rong Z, Chen H, Jiang X. (2007b). Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration. J Control Release, 121, 156–167.
  • Gao XL, Tao WX, Lu W, Zhang QZ, Zhang Y, Jiang XG, Fu SK. (2006). Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration. Biomaterials, 27, 3482–3490.
  • Geneser F. (1990). Histologi. Copenhagen: Munksgaard.
  • Goppert TM, Muller RH. (2005). Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns. J Drug Target, 13, 179–187.
  • Hanson LR, Frey WH, II. (2008). Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci, 9(Suppl. 3), S5.
  • Illum L. (2000). Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci, 11, 1–18.
  • Illum L. (2007). Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems? J Pharm Sci, 96, 473–483.
  • Jansson B. (2004). Models for the Transfer of Drugs from the Nasal Cavity to the Central Nervous System. Thesis Uppsala university, Uppsala, Sweden.
  • Kawashima Y, Yamamoto H, Takeuchi H, Kuno Y. (2000). Mucoadhesive dl-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharm Dev Technol, 5, 77–85.
  • Khanvilkar K, Donovan MD, Flanagan DR. (2001). Drug transfer through mucus. Adv Drug Del Rev, 48, 173–193.
  • Kristensson K, Olsson Y. (1971). Uptake of exogenous proteins in mouse olfactory cells. Acta Neuropathol, 19, 145–154.
  • Kronberg B, Dahlman A, Carlfors J, Karlsson J, Artursson P. (1990). Preparation and evaluation of sterically stabilized liposomes: colloidal stability, serum stability, macrophage uptake, and toxicity. J Pharm Sci, 79, 667–671.
  • Kumar M, Misra A, Babbar AK, Mishra AK, Mishra P, Pathak K. (2008). Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int J Pharm, 358, 285–291.
  • Lai SK, O’Hanlon DE, Harrold S, Man ST, Wang YY, Cone R, Hanes J. (2007). Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci USA, 104, 1482–1487.
  • Lai SK, Wang YY, Cone R Wirtz D, Hanes J. (2009). Altering mucus rheology to “solidify” human mucus at the nanoscale. Plus One, 4, e4294.
  • Matsuzaki O. (1995). Numbers of olfactory receptor-cells and pine structure of olfactory nerves in various birds. Zool Sci, 12, 117–123.
  • Mistry A. (2009). The Development and Application of Biological Models for Evaluation of Direct Nose-to-Brain Drug Delivery Systems. Thesis Nottingham University, Nottingham, UK.
  • Morrison EE, Costanzo RM. (1992). Morphology of olfactory epithelium in humans and other vertebrates. Microsc Res Tech, 23, 49–61.
  • Norris DA, Sinko PJ. (1997). Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin. J Appl Polymer Sci, 63, 1481–1492.
  • Nyengaard JR. (1999). Stereologic methods and their application in kidney research. J Am Soc Nephrol, 10, 1100–1123.
  • Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C. (2004). Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol, 16, 437–445.
  • Sims DE, Horne MM. (1997). Heterogeneity of the composition and thickness of tracheal mucus in rats. Am J Physiol-Lung Cell Mol Physiol, 17, L1036–L1041.
  • Tangboriboonrat P, Buranabunya U, Sangribsub S. (2003). Heterocoagulation of polychloroprene on natural rubber latex particles for use in the preparation of toughened polystyrene. J Appl Polym Sci, 87, 9–13.
  • Thorne RG, Pronk GJ, Padmanabhan V, Frey WH. (2004). Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience, 127, 481–496.
  • Vila A, Gill H, McCallion O, Alonso MJ. (2004). Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. J Control Release, 98, 231–244.
  • Vila A, Sanchez A, Evora C, Soriano I, McCallion O, Alonso MJ. (2005). PLA-PEG particles as nasal protein carriers: the influence of the particle size. Int J Pharm, 292, 43–52.
  • Wang J, Liu Y, Jiao F, Lao F, Li W, Gu Y, Li Y, Ge C, Zhou G, Li B, Zhao Y, Chai Z, Chen C. (2008a). Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO2 nanoparticles. Toxicology, 254, 82–90.
  • Wang Y-Y, Lai SK, Suk JS, Pace A, Cone R, Hanes J. (2008b). Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that “slip” through the human mucus barrier. Angew Chem Int Ed Engl, 47, 9726–9729.
  • Wang X, Chi N, Tang X. (2008c). Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur J Pharm Biopharm, 70, 735–740.
  • Zhang Q, Jiang X, Jiang W, Lu W, Su L, Shi Z. (2004). Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain. Int J Pharm, 275, 85–96.
  • Zhang Q-Z, Zha L-S, Zhang Y, Jiang W-M, Lu W, Shi Z-Q, Jiang X-G, Fu S-K. (2006). The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats. J Drug Target, 14, 281–290.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.